These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34431968)

  • 1. Trends in Funding and Acquisition of Surgical Practices by Private Equity Firms in the US From 2000 to 2020.
    Billig JI; Kotsis SV; Chung KC
    JAMA Surg; 2021 Nov; 156(11):1066-1068. PubMed ID: 34431968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Private capital investments in health care provision through mergers and acquisitions: from long-term to acute care.
    Angeli F; Maarse H
    Int J Health Plann Manage; 2016 Oct; 31(4):e290-e301. PubMed ID: 26814369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Make no small plans. Easy-to-track finances of private healthcare services draw attention--and big money--from equity investor firms.
    Galloro V
    Mod Healthc; 2002 Mar; 32(9):30-2. PubMed ID: 11922007
    [No Abstract]   [Full Text] [Related]  

  • 4. Capital finance and ownership conversions in health care.
    Robinson JC
    Health Aff (Millwood); 2000; 19(1):56-71. PubMed ID: 10645073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited potential. Private-equity deals come with conditions.
    Evans M
    Mod Healthc; 2012 Jan; 42(5):16-7. PubMed ID: 22356076
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent Trends in Private Equity Acquisition of Orthopaedic Practices in the United States.
    Boddapati V; Danford NC; Lopez CD; Levine WN; Lehman RA; Lenke LG
    J Am Acad Orthop Surg; 2022 Apr; 30(8):e664-e672. PubMed ID: 35077400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cash-strapped biotechs find financing alternative.
    Mitchell P
    Nat Biotechnol; 2004 Sep; 22(9):1057-8. PubMed ID: 15340452
    [No Abstract]   [Full Text] [Related]  

  • 8. When will we escape from the medical funding industry's 'spin'?
    Groenveld L
    S Afr Med J; 2013 Jan; 103(1):7. PubMed ID: 23346568
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquisition financing.
    Adler S
    Contemp Longterm Care; 2000 Aug; 23(8):35-6, 38. PubMed ID: 11185114
    [No Abstract]   [Full Text] [Related]  

  • 10. Joint ventures. Money for mission.
    Serb C
    Hosp Health Netw; 1998 Apr; 72(8):57-8. PubMed ID: 9582922
    [No Abstract]   [Full Text] [Related]  

  • 11. Investing in the twenty-first century hospital.
    Manning DL
    Health Aff (Millwood); 1997; 16(2):108-11. PubMed ID: 9086656
    [No Abstract]   [Full Text] [Related]  

  • 12. Private equity still lurking. Apria deal shows sector still watching healthcare.
    Galloro V
    Mod Healthc; 2008 Jun; 38(25):16. PubMed ID: 18683313
    [No Abstract]   [Full Text] [Related]  

  • 13. Cutting edge. Surgical company is poised for growth--or acquisition.
    Japsen B
    Mod Healthc; 1998 Apr; 28(17):34. PubMed ID: 10179160
    [No Abstract]   [Full Text] [Related]  

  • 14. Striking out on their own. New "no-hospital" companies joining the game, but so far they're battling close to zero.
    Kirchheimer B
    Mod Healthc; 1999 Jul; 29(29):8-9. PubMed ID: 10538969
    [No Abstract]   [Full Text] [Related]  

  • 15. Equity financing of capital acquisitions.
    Jones KR
    Semin Nurse Manag; 2000 Mar; 8(1):5-6. PubMed ID: 11075180
    [No Abstract]   [Full Text] [Related]  

  • 16. Venture capitalists up interests in niche healthcare services firms.
    Lutz S
    Mod Healthc; 1994 Jun; 24(23):42. PubMed ID: 10134259
    [No Abstract]   [Full Text] [Related]  

  • 17. By the numbers. Largest healthcare financing companies ranked by amount of syndicated loans in the healthcare sector underwritten from Sept. 1, 2006, through April 9, 2007.
    Mod Healthc; 2007 May; 37(21):46. PubMed ID: 17824191
    [No Abstract]   [Full Text] [Related]  

  • 18. Other investors also on healthcare trail.
    Galloro V
    Mod Healthc; 2002 Mar; 32(9):31. PubMed ID: 11922008
    [No Abstract]   [Full Text] [Related]  

  • 19. Shareholders flex their muscles.
    Thiel K
    Nat Biotechnol; 2008 Jan; 26(1):19-21. PubMed ID: 18183007
    [No Abstract]   [Full Text] [Related]  

  • 20. A better prescription for drug-development financing.
    Kessel M; Frank F
    Nat Biotechnol; 2007 Aug; 25(8):859-66. PubMed ID: 17687358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.